Armstrong, A. J., Halabi, S., Healy, P., Lee, W. R., Koontz, B. F., Moul, J. W., . . . George, D. J. (2016). A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy. Prostate Cancer and Prostatic Diseases, 19(1), 100-106. https://doi.org/10.1038/pcan.2015.59
Παραπομπή σε μορφή Chicago (17η εκδ.)Armstrong, A J., et al. "A Phase 2 Multimodality Trial of Docetaxel/prednisone with Sunitinib Followed by Salvage Radiation Therapy in Men with PSA Recurrent Prostate Cancer After Radical Prostatectomy." Prostate Cancer and Prostatic Diseases 19, no. 1 (2016): 100-106. https://doi.org/10.1038/pcan.2015.59.
Παραπομπή σε μορφή MLA (9th εκδ.)Armstrong, A J., et al. "A Phase 2 Multimodality Trial of Docetaxel/prednisone with Sunitinib Followed by Salvage Radiation Therapy in Men with PSA Recurrent Prostate Cancer After Radical Prostatectomy." Prostate Cancer and Prostatic Diseases, vol. 19, no. 1, 2016, pp. 100-106, https://doi.org/10.1038/pcan.2015.59.